These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 36186141)
21. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
22. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028 [TBL] [Abstract][Full Text] [Related]
23. Blood-Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease. Shin Y; Choi SH; Kim E; Bylykbashi E; Kim JA; Chung S; Kim DY; Kamm RD; Tanzi RE Adv Sci (Weinh); 2019 Oct; 6(20):1900962. PubMed ID: 31637161 [TBL] [Abstract][Full Text] [Related]
24. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease. Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560 [TBL] [Abstract][Full Text] [Related]
25. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906 [TBL] [Abstract][Full Text] [Related]
26. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease. Šimić G; Španić E; Langer Horvat L; Hof PR Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331 [TBL] [Abstract][Full Text] [Related]
27. Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease. Barisano G; Montagne A; Kisler K; Schneider JA; Wardlaw JM; Zlokovic BV Nat Cardiovasc Res; 2022 Feb; 1(2):108-115. PubMed ID: 35450117 [TBL] [Abstract][Full Text] [Related]
29. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy. Xin SH; Tan L; Cao X; Yu JT; Tan L Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319 [TBL] [Abstract][Full Text] [Related]
30. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Deane R; Zlokovic BV Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246 [TBL] [Abstract][Full Text] [Related]
31. Neural stem cell therapy for neurovascular injury in Alzheimer's disease. Boese AC; Hamblin MH; Lee JP Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762 [TBL] [Abstract][Full Text] [Related]
32. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1. Xu QQ; Su ZR; Hu Z; Yang W; Xian YF; Lin ZX Phytomedicine; 2022 Nov; 106():154441. PubMed ID: 36108371 [TBL] [Abstract][Full Text] [Related]
33. Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease. Wang D; Chen F; Han Z; Yin Z; Ge X; Lei P Front Cell Neurosci; 2021; 15():695479. PubMed ID: 34349624 [TBL] [Abstract][Full Text] [Related]
34. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease. Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499 [TBL] [Abstract][Full Text] [Related]
35. [Focused ultrasound as a non-invasive method with therapeutic potential in patients with Alzheimer's disease]. Kovalenko EA; Makhnovich EV; Osinovskaya NA; Bogolepova AN Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):38-45. PubMed ID: 36279227 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms. Dehghani R; Rahmani F; Rezaei N Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357 [TBL] [Abstract][Full Text] [Related]
37. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
38. Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings. de Oliveira J; Kucharska E; Garcez ML; Rodrigues MS; Quevedo J; Moreno-Gonzalez I; Budni J Cells; 2021 Sep; 10(10):. PubMed ID: 34685563 [TBL] [Abstract][Full Text] [Related]
39. Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target. Sousa JA; Bernardes C; Bernardo-Castro S; Lino M; Albino I; Ferreira L; Brás J; Guerreiro R; Tábuas-Pereira M; Baldeiras I; Santana I; Sargento-Freitas J Front Aging Neurosci; 2023; 15():1102809. PubMed ID: 36875694 [TBL] [Abstract][Full Text] [Related]
40. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]